blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2565178

EP2565178 - LPA Receptor Antagonists [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.02.2015
Database last updated on 14.06.2024
Most recent event   Tooltip27.02.2015Application deemed to be withdrawnpublished on 01.04.2015  [2015/14]
Applicant(s)For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
[2013/10]
Inventor(s)01 / Terakado, Masahiko
c/o Minase Research Institiute
Ono Pharmaceutical Co. Ltd.
1-1, Sakurai 3-chome Shimamoto-cho
Mishima-gun Osaka 618-8585 / JP
02 / Nakade, Shinji
c/o Minase Research Institiute
Ono Pharmaceutical Co. Ltd.
1-1, Sakurai 3-chome Shimamoto-cho
Mishima-gun Osaka 618-8585 / JP
03 / Seko, Takuya
c/o Ono Pharmaceutical Co. Ltd.
1-5 Doshomachi 2-chome Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
04 / Takaoka, Yoshikazu
c/o Minase Research Institiute
Ono Pharmaceutical Co. Ltd.
1-1, Sakurai 3-chome Shimamoto-cho
Mishima-gun Osaka 618-8585 / JP
 [2013/10]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[N/P]
Former [2013/10]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Anwaltssozietät
Leopoldstrasse 4
80802 München / DE
Application number, filing date12007801.928.05.2003
[2013/10]
Priority number, dateJP2002029113703.10.2002         Original published format: JP 2002291137
[2013/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2565178
Date:06.03.2013
Language:EN
[2013/10]
Search report(s)(Supplementary) European search report - dispatched on:EP31.01.2013
ClassificationIPC:C07C65/40, C07C235/52, A61K31/192, A61K31/216, A61K31/402, A61K31/4035, A61K31/404, A61K31/41, A61K31/4184, A61K31/4402, A61K31/445
[2013/10]
CPC:
C07D211/96 (EP,US); A61P1/16 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P13/00 (EP); A61P13/02 (EP);
A61P13/08 (EP); A61P13/10 (EP); A61P13/12 (EP);
A61P17/00 (EP); A61P17/06 (EP); A61P19/10 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P27/02 (EP);
A61P27/06 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P9/10 (EP); C07C217/58 (EP,US); C07C233/22 (EP,US);
C07C233/51 (EP,US); C07C233/63 (EP,US); C07C233/73 (EP,US);
C07C233/87 (EP,US); C07C235/34 (EP,US); C07C235/48 (EP,US);
C07C235/52 (EP,US); C07D207/12 (EP,US); C07D207/327 (EP,US);
C07D209/08 (EP,US); C07D209/12 (EP,US); C07D209/14 (EP,US);
C07D209/46 (EP,US); C07D213/65 (EP,US); C07D213/89 (EP,US);
C07D217/06 (EP,US); C07D231/12 (EP,US); C07D231/14 (EP,US);
C07D235/12 (EP,US); C07D239/91 (EP,US); C07D257/04 (EP,US);
C07D277/36 (EP,US); C07D277/56 (EP,US); C07D279/08 (EP,US);
C07D307/68 (EP,US); C07D317/68 (EP,US); C07D333/70 (EP,US);
C07C2601/08 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2013/10]
TitleGerman:LPA-Rezeptorantagonisten[2013/10]
English:LPA Receptor Antagonists[2013/10]
French:Antagonistes du récepteur LPA[2013/10]
Examination procedure19.11.2012Examination requested  [2013/10]
05.09.2013Amendment by applicant (claims and/or description)
29.10.2013Despatch of a communication from the examining division (Time limit: M04)
05.03.2014Reply to a communication from the examining division
26.05.2014Communication of intention to grant the patent
07.10.2014Application deemed to be withdrawn, date of legal effect  [2015/14]
11.11.2014Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2015/14]
Parent application(s)   TooltipEP03733131.1  / EP1553075
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030733131) is  22.11.2010
Fees paidRenewal fee
19.11.2012Renewal fee patent year 03
19.11.2012Renewal fee patent year 04
19.11.2012Renewal fee patent year 05
19.11.2012Renewal fee patent year 06
19.11.2012Renewal fee patent year 07
19.11.2012Renewal fee patent year 08
19.11.2012Renewal fee patent year 09
19.11.2012Renewal fee patent year 10
28.05.2013Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
31.05.201412   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO2004002530  (ONO PHARMACEUTICAL CO [JP], et al) [E] 1-4 * the whole document *;
 EP1550461  [ ] (ONO PHARMACEUTICAL CO [JP]) [ ] * Compounds of formulae III-7 to III-8-3; pages 37-38 *;
 [A]DE19939463  (BOEHRINGER INGELHEIM PHARMA [DE]) [A] 1-4 * the whole document *;
 [A]WO0229001  (UNIV VIRGINIAN PATENT FOUNDATI [US], et al) [A] 1-4 * the whole document *
by applicantWO02062389
 WO03007991
 EP0443983
 US2868691
 US3095355
    - MOL. PHARMACOL., (200012), vol. 58, no. 6, pages 1188 - 96
    - J. PHARM. PHARMACOL., (1991), vol. 43, page 774
    - J. PHARM. PHARMACOL., (1982), vol. 34, page 514
    - J CELLULAR PHYSIOL., (1998), vol. 174, page 261
    - J. UROL., (2000), vol. 163, page 1027
    - AM. J PHYSIOL. LUNG CELL MOL. PHYSIOL., (2002), vol. 282, no. 1, page L91
    - MOL. CELL BIOL., (1998), vol. 18, no. 12, page 7119
    - CLIN. SCIENCE, (1999), vol. 96, page 431
    - BIOCHEM. BIOPHYS. RES. COMMUN., (1998), vol. 248, page 436
    - AM. J. PHYSIOL., (1994), page 267
    - CELL PHYSIOL., vol. 36, page C204
    - AM. J. PHYSIOL. CELL PHYSIOL., (2000), vol. 278, no. 3, page C612
    - PROC. NATL. ACAD. SCI. USA, (1999), vol. 96, page 5233
    - J. CLIN. INVEST., (1998), vol. 101, page 1431
    - BIOCHEM BIOPHYS RES COMMUN., (19921215), vol. 193, no. 2, page 497
    - J. IMUUNOL., (1999), vol. 162, page 2049
    - BIOCHEM. BIOPHYS. RES. COMMUN., (1981), vol. 99, page 391
    - PROC. NATL. ACAD SCI. USA, (2000), vol. 97, page 13384
    - IVAKUHIN NO KAIHATSU, (1990), vol. 7, pages 163 - 198
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.